▶
Beyond the scale, obesity in the age of GLP-1s
Why are obesity rates rising, and how are GLP‑1 medicines changing the conversation?
EMA expert Bart van der Schueren breaks down what we know about obesity as a chronic disease and why weight is about far more than diet and exercise.
Watch the full episode on Inside EMA.
